Searched for
ARTHRITIS DRUG MOLNUPIRAVIR
WHO 'strongly advises against' use of two COVID-19 antibody therapies, says British Medical JournalThe WHO Guideline Development Group of international experts noted that antibody drugs sotrovimab and casirivimab-imdevimab are not recomme...- COVID antiviral Molnupiravir to be tested in RECOVERY trial on hospitalised patientsThe RECOVERY Trial was launched as an emergency response in March 2020 and has so far discovered three effective treatments for COVID-19 - ...
- 8 vaccines, 4 treatments in India's COVID-19 arsenalMeanwhile, India logged 653 cases of the Omicron variant of coronavirus across 21 states and UTs so far out of which 186 have recovered or ...
- Yashoda Hospitals joins Natco for clinical trials of Molnupiravir for Covid patientsPre-clinical (animal) studies have found that Molnupiravir has remarkably reduced SARS-CoV-2 load and was found to have completely suppress...
- Cipla says supply of COVID-19 drug remdesivir catching up with demandBackorders and complaints over low supply started moderating in the second week of May, the drugmaker said, after it began ramping up produ...
- Natco Seeks emergency approval to launch Molnupiravir for Covid-19 in IndiaMolnupiravir was originally developed to treat influenza before US-based Merck initiated research to repurpose drug for use against SARS-Co...
Load More